If you've spent time researching wakefulness-promoting medications, you've almost certainly come across two names: modafinil and armodafinil. They're frequently discussed together, and for good reason ...

Modafinil, available under the brand name Provigil, is a central nervous system stimulant drug. This means that it helps a person feel awake and focused. While there is no cure for the disease, ...

Modafinil is approved by the Food and Drug Administration (FDA) to increase wakefulness in adults with daytime sleepiness due to certain conditions. These include: narcolepsy obstructive sleep apnea ...

Latest research presented at the meeting of the European Association for the Study of Diabetes has associated daytime napping and drowsiness with an increased risk of Type 2 diabetes. Reuters ...

In up-all-night, work-work-work America, a prescription medication like modafinil was sure to make major inroads from the get-go. And, whether you call this novel stay-awake drug by its commercial ...

Both modafinil and Adderall are prescribed to treat narcolepsy, but Adderall is also used for ADHD, while modafinil is used for obstructive sleep apnea and shift work disorder. While both medications ...

Modafinil (2-[(Diphenylmethyl) sulfinyl] acetamide; brand name Provigil in the United States) is a novel wake-promoting agent first marketed in France in the early 1990s, as a treatment for the ...

Previous research has supported the effectiveness of modafinil in treating children with ADHD. These investigators used a smaller and more easily swallowed tablet than the one now on the market. They ...

Common complaints among shift workers are sleep disruptions and increased sleepiness while working, which may contribute to shift workers being more susceptible to diminished performance and ...

You can also listen to William Saletan read this piece. William Saletan Will Saletan writes about politics, science, technology, and other stuff for Slate. He’s the author of Bearing Right. All over ...

If you could take a pill that will make you better at your job, with few or no negative consequences, would you do it? In a meta-analysis recently published in European Neuropsychopharmacology, ...